Sopra Steria Group

Gradual recovery path

25/07/25 -"As expected, the decline in organic revenue slowed in Q2 2025 compared to Q1, with notable improvements in France and the UK, and limited progress in Other Europe. The operating margin on business ..."

PDF page sample
Pages
53
Language
English
Published on
25/07/25
Download
You may also be interested by these reports :
01/08/25
In H1 2025, Atos delivered results that were broadly in line. Organic revenue fell sharply, but the operating margin began to recover, thanks to the ...
30/07/25
Capgemini posted a modest Q2 2025 revenue increase at constant currency, driven by accelerating growth in North America, the UK, and Asia ...
25/07/25
The decrease in organic revenue in Q2 2025 showed no improvement compared to Q1. The automotive sector remained a significant drag, and only three ...
25/07/25
As expected, the decline in organic revenue slowed in Q2 2025 compared to Q1, with notable improvements in France and the UK, and limited progress in ...

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO